Baseline Characteristics Module
The Baseline Characteristics Module provides demographic and baseline characteristics information for participants in a clinical trial. This module includes data such as population descriptions and the types of units analyzed, helping researchers understand the baseline characteristics of study participants.
Baseline Characteristics Module path is as follows:
Study -> Results Section -> Baseline Characteristics Module
Baseline Characteristics Module
Ignite Creation Date:
2025-12-24 @ 4:03 PM
Ignite Modification Date:
2025-12-25 @ 2:05 PM
NCT ID:
NCT01458366
Population Description:
Bendamustine at 50mg/m2 was the dose level -1. No dose limiting toxicities were noted in the first Bendamustine dose level (70mg/m2) so a reduction to 50mg/m2 was not needed and therefore no patients were enrolled at the dose level -1.
Study:
NCT01458366
Study Brief:
Results Section:
NCT01458366